The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2009

Filed:

May. 21, 2004
Applicants:

Inder Raj S. Makin, Loveland, OH (US);

T. Douglas Mast, Cincinnati, OH (US);

Michael H. Slayton, Tempe, AZ (US);

Peter G. Barthe, Phoenix, AZ (US);

Jeffrey D. Messerly, Cincinnati, OH (US);

Waseem Faidi, Clifton Park, NY (US);

Megan M. Runk, Cincinnati, OH (US);

Brian D. O'connor, Lawrenceburg, IN (US);

Christopher J. Park, Oregonia, OH (US);

Paul M. Jaeger, Mesa, AZ (US);

Inventors:

Inder Raj S. Makin, Loveland, OH (US);

T. Douglas Mast, Cincinnati, OH (US);

Michael H. Slayton, Tempe, AZ (US);

Peter G. Barthe, Phoenix, AZ (US);

Jeffrey D. Messerly, Cincinnati, OH (US);

Waseem Faidi, Clifton Park, NY (US);

Megan M. Runk, Cincinnati, OH (US);

Brian D. O'Connor, Lawrenceburg, IN (US);

Christopher J. Park, Oregonia, OH (US);

Paul M. Jaeger, Mesa, AZ (US);

Assignee:

Ethicon Endo-Surgery, Inc., Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/18 (2006.01);
U.S. Cl.
CPC ...
Abstract

An ultrasound medical system includes an interstitial end effector. The interstitial end effector is interstitially insertable into patient tissue, includes at least one medical-treatment ultrasound transducer, and includes at least one end-effector-tissue-track ablation device. One method for ultrasonically treating a lesion in a patient includes the steps of obtaining the interstitial end effector and inserting it into the patient creating a tissue track which is surrounded by patient tissue and which ends at the distal end of the inserted interstitial end effector. Other steps include ultrasonically ablating the lesion using the at-least-one medical-treatment ultrasound transducer, using the at-least-one end-effector-tissue-track ablation device to ablate the patient tissue surrounding the tissue track along substantially the entire tissue track, and withdrawing the end effector from the patient.


Find Patent Forward Citations

Loading…